These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30090010)

  • 41. Hybrid Therapy as First-Line Regimen for Helicobacter pylori Eradication in Populations with High Antibiotic Resistance Rates.
    Song Z; Zhou L; Zhang J; He L; Bai P; Xue Y
    Helicobacter; 2016 Oct; 21(5):382-8. PubMed ID: 26809022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rifabutin-based Fourth and Fifth-line Rescue Therapy in Patients with for
    Sung J; Kim N; Park YH; Hwang YJ; Kwon S; Na G; Choi JY; Kang JB; Kim HR; Kim JW; Lee DH
    Korean J Gastroenterol; 2017 Feb; 69(2):109-118. PubMed ID: 28239079
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fourteen- vs seven-day bismuth-based quadruple therapy for second-line Helicobacter pylori eradication.
    Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
    World J Gastroenterol; 2015 Jul; 21(26):8132-9. PubMed ID: 26185386
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease.
    Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
    World J Gastroenterol; 2015 Apr; 21(16):5032-8. PubMed ID: 25945019
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of high-dose dual therapy for Helicobacter pylori rescue therapy: A systematic review and meta-analysis.
    Gao CP; Zhou Z; Wang JZ; Han SX; Li LP; Lu H
    J Dig Dis; 2016 Dec; 17(12):811-819. PubMed ID: 27977071
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systematic review with meta-analysis: Vonoprazan, a potent acid blocker, is superior to proton-pump inhibitors for eradication of clarithromycin-resistant strains of Helicobacter pylori.
    Li M; Oshima T; Horikawa T; Tozawa K; Tomita T; Fukui H; Watari J; Miwa H
    Helicobacter; 2018 Aug; 23(4):e12495. PubMed ID: 29873436
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of supplementation with rebamipide for Helicobacter pylori eradication therapy: a systematic review and meta-analysis.
    Nishizawa T; Nishizawa Y; Yahagi N; Kanai T; Takahashi M; Suzuki H
    J Gastroenterol Hepatol; 2014 Dec; 29 Suppl 4():20-4. PubMed ID: 25521728
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week-a meta-analysis of efficacy.
    Gisbert JP; González L; Calvet X; Roqué M; Gabriel R; Pajares JM
    Aliment Pharmacol Ther; 2000 Sep; 14(9):1141-50. PubMed ID: 10971230
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Standard triple therapy in Helicobacter pylori eradication in Turkey: Systematic evaluation and meta-analysis of 10-year studies.
    Sezgin O; Aydın MK; Özdemir AA; Kanık AE
    Turk J Gastroenterol; 2019 May; 30(5):420-435. PubMed ID: 31060997
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Meta-analysis: High-dose vs. low-dose metronidazole-containing therapies for Helicobacter pylori eradication treatment.
    Ji Y; Lu H
    PLoS One; 2018; 13(1):e0189888. PubMed ID: 29370199
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of tailored Helicobacter pylori eradication treatment based on clarithromycin susceptibility and maintenance of acid secretion.
    Sugimoto M; Uotani T; Sahara S; Ichikawa H; Yamade M; Sugimoto K; Furuta T
    Helicobacter; 2014 Aug; 19(4):312-8. PubMed ID: 24690010
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Eradication of Helicobacter pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2002].
    Buzás GM; Józan J
    Orv Hetil; 2004 Oct; 145(40):2035-41. PubMed ID: 15559530
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of genotypic susceptibility-guided tailored therapy for Helicobacter pylori infection: A systematic review and single arm meta-analysis.
    Lin K; Huang L; Wang Y; Li K; Ye Y; Yang S; Li A
    Helicobacter; 2023 Dec; 28(6):e13015. PubMed ID: 37634236
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High dose dual therapy versus bismuth quadruple therapy for Helicobacter pylori eradication treatment: A systematic review and meta-analysis.
    Yang X; Wang JX; Han SX; Gao CP
    Medicine (Baltimore); 2019 Feb; 98(7):e14396. PubMed ID: 30762742
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: A Network Meta-analysis.
    Rokkas T; Gisbert JP; Malfertheiner P; Niv Y; Gasbarrini A; Leja M; Megraud F; O'Morain C; Graham DY
    Gastroenterology; 2021 Aug; 161(2):495-507.e4. PubMed ID: 33839101
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of bismuth-containing quadruple treatment and concomitant treatment for first-line Helicobacter pylori eradication: A systematic review and meta-analysis.
    Guo B; Cao NW; Zhou HY; Chu XJ; Li BZ
    Microb Pathog; 2021 Mar; 152():104661. PubMed ID: 33249167
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of moxifloxacin-based sequential and hybrid therapy for first-line Helicobacter pylori eradication.
    Hwang JJ; Lee DH; Yoon H; Shin CM; Park YS; Kim N
    World J Gastroenterol; 2015 Sep; 21(35):10234-41. PubMed ID: 26401089
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of Helicobacter pylori eradication therapy on functional dyspepsia: a meta-analysis of randomized controlled studies with 12-month follow-up.
    Zhao B; Zhao J; Cheng WF; Shi WJ; Liu W; Pan XL; Zhang GX
    J Clin Gastroenterol; 2014 Mar; 48(3):241-7. PubMed ID: 24002127
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Seven-day quintuple regimen as a rescue therapy for Helicobacter pylori eradication.
    Mansour-Ghanaei F; Joukar F; Naghipour MR; Forouhari A; Saadat SM
    World J Gastroenterol; 2015 Jan; 21(2):661-6. PubMed ID: 25593496
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Systematic Review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection.
    Chen MJ; Chen CC; Chen YN; Chen CC; Fang YJ; Lin JT; Wu MS; Liou JM;
    Am J Gastroenterol; 2018 Oct; 113(10):1444-1457. PubMed ID: 30171216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.